You're currently following this author! Click to unsubscribe from email alerts. When Dr. Homoud Aldahash started the three-hour process of removing a tumor about the size of a walnut from a patient's ...

A medical device company seeking to commercialize a less invasive treatment for hydrocephalus — a condition caused by excess fluid buildup in the brain — secured $85 million in Series C financing on ...

CereVasc raised $85 million in Series C funding to advance its minimally invasive eShunt system, which aims to treat hydrocephalus without traditional brain shunt surgery. The company is preparing for ...

Siddiqui, who is chief executive officer and chief medical officer of the Jacobs Institute, performed indirect bypass, encephaloduroarteriosynagiosis (EDAS) surgery to restore adequate blood supply to ...

Deep beneath the skin of hundreds of thousands of children worldwide, a slender silicone tube quietly performs one of ...

When Dr. Homoud Aldahash started the three-hour process of removing a tumor about the size of a walnut from a patient's brain, it was an experience unlike any other in his 25 years as a neurosurgeon.